Therapeutic strategy for the treatment with hypertensive renal injury

Koichi Hayashi

研究成果: Review article査読


Hypertension constitutes a pivotal determinant of the progression of renal disease, which would raise the risk for cardiovascular events. From the standpoint of renal micro-circulation, correction of glomerular hypertension could retard the development of renal injury, which is attainable by the reduction in renal efferent arteriolar resistance as well as systemic blood pressure. Although both ACE inhibitors and angiotensin receptor blockers are established as a tool for improving glomerular hypertension, whether calcium antagonists ameliorate this abnormality remains unclear. However, recent clinical trials including ALLHAT and INSIGHT demonstrate a beneficial action of amlodipine and nifedipine on the development of renal injury. Therefore, calcium antagonists can be used not only as a first line drug, but also as add-on therapy that could potentiate the hypotensive action of underlying medication.

ジャーナルNippon rinsho. Japanese journal of clinical medicine
出版ステータスPublished - 2004 1月

ASJC Scopus subject areas

  • 医学一般


「Therapeutic strategy for the treatment with hypertensive renal injury」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。